Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

A new study shows that receiving an updated COVID vaccine reduced people’s risk of severe disease and death in all age groups ...

Getting a COVID booster could save your life, even if you’ve had multiple prior infections and vaccinations. A study, ...

GoodRx reports that CDC now recommends COVID-19 vaccinations be decided with healthcare professionals, stressing personalized ...

These five stocks of well-run companies yield at least 6% and look like timely buys now as interest rates trend lower.

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

Health officials say the best way to prevent death or hospitalizations from the flu and other respiratory viruses is to get ...

Seasonal influenza vaccines are also available at FCBOH clinics. The flu is a contagious respiratory virus that spreads ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...